Aortic Valve Endocarditis Post Ventricular Septal Defect Device Closure: Case Report

Abstract

Ventricular septal defect (VSD) is one of the most common form of congenital cardiac disease (CHD) in children especially perimembranous type [1,2]. Surgical closure of VSD carries a minimal risk of morbidity and mortality, however transcatheter closure is less invasive, has a faster recovery and requires less hospital stay time [3]. Percutaneous techniques have been developed in order to reduce the impact of such drawback of 
surgery [4]. Transcatheter VSD closure avoids extracorporeal circulatory support of surgical approach and has the benefit of shorter recovery time [5]. The coil system is developed specifically for transcatheter occlusion of VSD. The incidence of endocarditis after device closure of VSD is extremely rare [3]. The aortic valve is the most common sit in IE, and its incidence is 
about 40% - 67%. Surgical intervention for aortic valve IE is about 60% -72%. Aortic valve replacement (AVR); is recommended as a standard surgical procedure [6].The risk of infective endocarditis (IE) is increased. In the past, antibiotic IE prophylaxis was recommended in risk situations for transient bacteremia. Nowadays, prevention of IE focuses on prevention measures like good dental health. In addition, IE is a rare occurrence with decreasing mortality [7].